Native Orthopaedics
Native Orthopaedics is a privately held medical device company founded in 2025 that develops and commercializes FDA-cleared soft-tissue repair systems for orthopedic sports medicine surgeons, anchored by its proprietary Dragonfly knotless retensioning and Zerofly metal-free fixation platforms.
- Company typePrivate
- Founded2025
- HeadquartersProvidence, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Native Orthopaedics does
Native Orthopaedics is a privately held medical device company headquartered in Providence, Rhode Island, founded in 2025 to commercialize soft-tissue repair technology for orthopedic sports medicine surgeons. The company's platform is built on two proprietary technologies: the Dragonfly quad-core 'trap within a trap' finger trap mechanism, which provides knotless fixation and intraoperative dynamic retensioning to recover tissue creep, and Zerofly, an integrated metal-free textile fixation button for cortical fixation. The commercial portfolio centers on the Native Root System for meniscal root repair, the Native ACL family (ACL Prime, Prime Zero, and Tibial Eminence Repair), the Native Bridge for bone-to-bone fixation, and supporting instruments including the RootFinder drill guide and Spear Passer suture passer. Manufacturing consists of single-use sterile-packaged surgical devices sold as procedural constructs.
The company monetizes through direct enterprise field sales of hardware, currently selling only in select U.S. locations with broader U.S. expansion planned. Customer segments are sports medicine surgeons and the hospitals and ambulatory surgical centers where they operate, with primary use cases in meniscal root repair, ACL/PCL repair, tibial eminence repair, MPFL repair, biceps tenodesis, AC separation repair, and Achilles tendon repair. Native Orthopaedics received its first FDA 510(k) clearance in April 2025 for the Native Root System, commenced commercial availability in May 2025, won the 2025 ACE Award at the AOSSM Annual Meeting, and secured additional FDA 510(k) clearances in March 2026 extending the Repair Construct across shoulder, foot and ankle, and knee indications, as well as clearance for the Native Bridge. The company is pre-Series A and is actively fundraising, with no disclosed revenue figures. Leadership combines surgeon-inventor (Dr. Christian Anderson, founding surgeon and CMO) with senior J&J MedTech commercial and R&D experience (CEO Tom Gamache, CTO Samuel Grossman, CMO Brian Morley).
Native Orthopaedics firmographics
Firmographics- Name
- Native Orthopaedics
- Legal name
- Native Orthopaedics, Inc.
- Website
- https://www.nativeortho.com
- Company type
- Private
- Founded year
- 2025
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Native Orthopaedics is a privately held medical device company founded in 2025 that develops and commercializes FDA-cleared soft-tissue repair systems for orthopedic sports medicine surgeons, anchored by its proprietary Dragonfly knotless retensioning and Zerofly metal-free fixation platforms.
- Ownership category
- akta.pro rank
Native Orthopaedics industry classification
Industry- Product category
- Orthopaedic Medical Devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Sports Medicine & Soft Tissue Repair Implants (Anchors/Grafts/Meniscal Repair) (HLAHAEAF)
Keywords
Where Native Orthopaedics is headquartered
LocationHeadquarters
- HQ city
- Providence
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Native Orthopaedics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Operations, Marketing or Sales, Personnel
Revenue model
- Medical Device Sales: Sale of single-use sterile-packed surgical devices and constructs for meniscal root repair and ACL repair procedures. Products include Dragonfly repair constructs, Zerofly soft buttons, No-Tie buttons, RootFinder drill guides, and Spear Passers. Revenue generated through direct sales to surgeons and hospitals.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
Native Orthopaedics product offering
Product offeringCore offering
Native Orthopaedics designs, manufactures, and sells soft-tissue repair implants and surgical instrumentation for orthopaedic sports medicine. Its portfolio covers meniscal root repair, ACL reconstruction, and tibial eminence repair, supported by proprietary Dragonfly quad-core finger-trap and Zerofly textile fixation technologies. Products are FDA 510(k) cleared and targeted at hospitals, ambulatory surgical centers, and orthopaedic surgeons performing sports-medicine procedures.
Product overview
Native Orthopaedics is a medical device company offering a platform of soft-tissue repair products for sports medicine, centered on its proprietary Dragonfly™ quad-core finger trap and Zerofly™ textile fixation technologies. The core portfolio includes the Native Root System for meniscal root repair (powered by Dragonfly with knotless fixation options including No-Tie and Zerofly buttons), the Native ACL product line (ACL Prime, Prime Zero, and Tibial Eminence Repair) all leveraging the same Dragonfly and Zerofly technology platform, and supporting instruments including RootFinder™ drill guide and Spear Passer. The company also received FDA clearance for Native Bridge for bone-to-bone fixation. The platform is designed around the principles of dynamic tensioning, preserving native anatomy, and surgical simplicity.
Differentiator
Problem solved
Functional benefit
Products and services
- Native Root System Soft-tissue meniscal root repair implant system for orthopaedic sports-medicine surgeons performing meniscal root repairs.
- Native ACL Prime ACL reconstruction implant system for orthopaedic surgeons performing primary ACL reconstruction procedures.
- Native Prime Zero Soft-tissue repair implant variant within the Native ACL/soft-tissue family for sports-medicine surgeons.
- Native Tibial Eminence Repair Tibial eminence fracture repair implant system for orthopaedic sports-medicine surgeons treating tibial eminence avulsion injuries.
- RootFinder Surgical instrumentation supporting meniscal root repair procedures for orthopaedic surgeons.
- Spear Passer Suture-passing surgical instrument used in arthroscopic soft-tissue repair procedures.
- No-Tie Button Button-style fixation implant used in orthopaedic soft-tissue repair procedures.
- Bow-Tie Button Bow-tie style button fixation implant used in orthopaedic soft-tissue repair procedures.
- Native Bridge Bridge soft-tissue repair implant for orthopaedic sports-medicine procedures.
Quantifiable outcome
- 290% increase in ultimate strength compared to market leader
- +6 more outcomes
Companies that use Native Orthopaedics
Customer profileNamed customers5 records
Segments2 records
Ideal customer profiles1 record
Native Orthopaedics technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Native Orthopaedics partnerships and signals
Strategic signalScale indicators5 records
Recent moves6 records
Expansion highlights5 records
Native Orthopaedics competitors and assessment
Company assessmentEmerging players
- Anika Therapeutics: Joint preservation and orthobiologics company focused on regenerative therapies for osteoarthritis and soft-tissue repair. Partial overlap with Native in non-surgical/regenerative sports medicine adjacencies and joint preservation philosophy.
- MiMedx: Public regenerative medicine company selling placental tissue allografts and orthobiologics for soft-tissue healing in sports medicine and orthopaedics. Adjacent competitor in the broader sports medicine soft-tissue repair market that Native targets.
- Treace Medical Concepts: Emerging orthopaedic medtech focused on foot and ankle procedures, with a similar founder-led commercialization playbook and KOL-driven launch model. Overlaps Native in foot/ankle soft-tissue indications such as Achilles tendon repair.
Broad incumbents
- Johnson & Johnson MedTech (DePuy Synthes Mitek Sports Medicine): J&J's orthopaedics and sports medicine arm (formerly DePuy Mitek) sells suture anchors, meniscal repair devices, and ACL reconstruction systems. Particularly relevant given Native's CEO and CTO are J&J MedTech alumni with deep familiarity — and direct competition — with this portfolio.
- Integra LifeSciences: Diversified surgical device and orthobiologics company with a presence in orthopaedic soft-tissue repair and specialty surgical instruments. Comparable in that it sells sterile surgical implants and instruments into the same OR call points.
- Smith+Nephew: Global medical device incumbent with a sizable Sports Medicine franchise (including acquired assets from Ceterix and Arthrocare) covering meniscal repair, ACL/PCL reconstruction, and shoulder soft-tissue fixation. Directly competes with Native across multiple indications and geographies.
- Zimmer Biomet: Global orthopaedics incumbent with a Sports Medicine franchise (formerly Biomet Sports Medicine) covering ligament repair, meniscal repair, and shoulder soft-tissue solutions. Competes with Native across multiple cleared indications.
- Stryker: Diversified medtech incumbent whose Sports Medicine business offers soft-tissue fixation, meniscal repair, and arthroscopic instruments. Overlaps Native's product categories and brings large installed base and salesforce scale.
Direct peers
- Conmed: Pure-play medical device company with a significant Sports Medicine and General Surgery franchise, offering meniscal repair, suture anchors, and arthroscopic instruments. Directly competes with Native in soft-tissue fixation for knee and shoulder procedures.
- Arthrex: The dominant privately held medical device company in sports medicine soft tissue repair, offering suture anchors, knotless fixation systems, meniscal repair devices, and ACL reconstruction instrumentation. Native competes directly against Arthrex's meniscal root and ACL repair portfolios in the same surgeon call points.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Native Orthopaedics social profiles
Digital presenceNative Orthopaedics compliance and trust
Trust signalCompliance2 records
Native Orthopaedics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Native Orthopaedics leadership team
Management profileNumber of profiles
Profiles4 records
Native Orthopaedics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Native Orthopaedics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Native Orthopaedics
What does Native Orthopaedics do?
Native Orthopaedics designs, manufactures, and sells soft-tissue repair implants and surgical instrumentation for orthopaedic sports medicine. Its portfolio covers meniscal root repair, ACL reconstruction, and tibial eminence repair, supported by proprietary Dragonfly quad-core finger-trap and Zerofly textile fixation technologies. Products are FDA 510(k) cleared and targeted at hospitals, ambulatory surgical centers, and orthopaedic surgeons performing sports-medicine procedures.
Is Native Orthopaedics a public or private company?
Native Orthopaedics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Native Orthopaedics founded?
Native Orthopaedics was founded in 2025. It employs 11 to 50 people.
Where is Native Orthopaedics based?
Native Orthopaedics is headquartered in Providence, United States, in the North America region.
How does Native Orthopaedics make money?
One revenue line is on record: medical Device Sales.
Who are Native Orthopaedics's main competitors?
Emerging players on record are Anika Therapeutics, MiMedx and Treace Medical Concepts. Broad incumbents are Johnson & Johnson MedTech (DePuy Synthes Mitek Sports Medicine), Integra LifeSciences, Smith+Nephew, Zimmer Biomet and Stryker. Direct peers are Conmed and Arthrex.
Does Native Orthopaedics have an API?
No public API is recorded for Native Orthopaedics.
What industry is Native Orthopaedics in?
Native Orthopaedics's product category is Orthopaedic Medical Devices. Its primary akta.pro industry code is HLAHAEAF, Sports Medicine & Soft Tissue Repair Implants (Anchors/Grafts/Meniscal Repair). Its NAICS code is 339113 and its SIC code is 3842.